Hosted on MSN23h
Kashiv Biosciences’ Phase I trial of KSHB002 injection meets primary endpoints
The biosimilar's safety and immunogenicity profiles were found to be comparable to those of the reference product in the ...
Food & Beverage News19h
FSSAI clarifies on methylcobalamin usage in supplements
The Food Safety and Standards Authority of India (FSSAI) has provided clarity on the regulatory framework surrounding the use of methylcobalamin, a form of Vitamin B12, in health supplements, medical ...